Error: Could not add to watchlist. X

Pronova BioPharma ASA

+ Watchlist
PRON:NO
Acquired
PRON:NO was acquired by BAS:GR
NOK
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (NOK) (TTM)
0.75
Market Cap (NOK)
-
Shares Outstanding (m)
300.833
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Pronova BioPharma AS researches, develops, and manufactures marine originated omega-3 derived pharmaceutical products.
ADDRESS
PO Box 420
Lysaker, 1327
Norway
PHONE
47-22-53-48-50
  • Gert Wilhelm Munthe
    Chairman
  • Rikke Tobiasson Reinemo
    Deputy Chairman
  • Morten Jurs
    Chief Executive Officer
  • Hilde Hermansen Steineger
    VP:Business Development
  • Goeran Gannedahl
    VP:Medical & Regulatory Affair
Show More